These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 15570423

  • 21. Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours.
    Durrant LG, Doran M, Austin EB, Robins RA.
    Int J Cancer; 1995 Mar 29; 61(1):62-6. PubMed ID: 7705934
    [Abstract] [Full Text] [Related]

  • 22. The biology of the 17-1A antigen (Ep-CAM).
    Balzar M, Winter MJ, de Boer CJ, Litvinov SV.
    J Mol Med (Berl); 1999 Oct 29; 77(10):699-712. PubMed ID: 10606205
    [Abstract] [Full Text] [Related]

  • 23. In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody.
    Roovers RC, van der Linden E, de Bruïne AP, Arends JW, Hoogenboom HR.
    Cancer Immunol Immunother; 2001 Mar 29; 50(1):51-9. PubMed ID: 11315510
    [Abstract] [Full Text] [Related]

  • 24. Clinical effects of a chimeric anti-EpCAM monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma.
    Liljefors M, Nilsson B, Fagerberg J, Ragnhammar P, Mellstedt H, Frödin JE.
    Int J Oncol; 2005 Jun 29; 26(6):1581-9. PubMed ID: 15870873
    [Abstract] [Full Text] [Related]

  • 25. A human cytokine/single-chain antibody fusion protein for simultaneous delivery of GM-CSF and IL-2 to Ep-CAM overexpressing tumor cells.
    Schanzer JM, Baeuerle PA, Dreier T, Kufer P.
    Cancer Immun; 2006 Feb 17; 6():4. PubMed ID: 16483188
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunogenic regions of the GA733-2 tumour-associated antigen recognised by autoantibodies of patients with colorectal carcinoma.
    Mosolits S, Steinitz M, Harmenberg U, Ruden U, Eriksson E, Mellstedt H, Fagerberg J.
    Cancer Immunol Immunother; 2002 Jun 17; 51(4):209-18. PubMed ID: 12012108
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
    Bellone S, Siegel ER, Cocco E, Cargnelutti M, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
    Int J Gynecol Cancer; 2009 Jul 17; 19(5):860-6. PubMed ID: 19574774
    [Abstract] [Full Text] [Related]

  • 33. Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients.
    Nagorsen D, Scheibenbogen C, Schaller G, Leigh B, Schmittel A, Letsch A, Thiel E, Keilholz U.
    Int J Cancer; 2003 Jun 10; 105(2):221-5. PubMed ID: 12673683
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55.
    Ullenhag GJ, Spendlove I, Watson NF, Indar AA, Dube M, Robins RA, Maxwell-Armstrong C, Scholefield JH, Durrant LG.
    Clin Cancer Res; 2006 Dec 15; 12(24):7389-96. PubMed ID: 17121873
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Analysis of the CDR3 length repertoire and the diversity of T cell receptor α and β chains in swine CD4+ and CD8+ T lymphocytes.
    Wang CY, Fang YX, Chen GH, Jia HJ, Zeng S, He XB, Feng Y, Li SJ, Jin QW, Cheng WY, Jing ZZ.
    Mol Med Rep; 2017 Jul 15; 16(1):75-86. PubMed ID: 28534993
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.